Inventor · disambiguated record
Alec Nathanson Flyer
Also filed as: FLYER ALEC · FLYER ALEC N · FLYER ALEC NATHANSON
13 granted patents·6 pending applications·25 citations·filing 2009–2022
86Inventor score
Top patents by PatentIndex Score
19 records- 0196US9834808B2Methods for rapid antibiotic susceptibility testingSELUX DIAGNOSTICS INC·Filed 2017·Granted Dec 5, 2017·15 cites·30 claims
- 0290US9127019B2Cortistatin analogues and synthesis thereofHARVARD COLLEGE·Filed 2014·Granted Sep 8, 2015·7 cites·19 claims
- 0376US10982254B2Methods for rapid antimicrobial susceptibility testingSELUX DIAGNOSTICS INC·Filed 2019·Granted Apr 20, 2021·0 cites·22 claims
- 0475US9714255B2Cortistatin analogues and syntheses thereofHARVARD COLLEGE·Filed 2015·Granted Jul 25, 2017·1 cites·36 claims
- 0574US8846656B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2012·Granted Sep 30, 2014·2 cites·3 claims
- 0673US2021317504A1Methods for rapid antimicrobial susceptibility testingSELUX DIAGNOSTICS INC·Filed 2021·Application pending·0 cites
- 0766US10501772B2Methods for rapid antimicrobial susceptibility testingSELUX DIAGNOSTICS INC·Filed 2017·Granted Dec 10, 2019·0 cites·45 claims
- 0864US2011190323A1Cortistatin analogues and syntheses thereofHARVARD COLLEGE·Filed 2009·Application pending·0 cites
- 0962US2022340573A11,2,4-oxadiazole derivatives as liver x receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1061US11813306B2Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2021·Granted Nov 14, 2023·0 cites·20 claims
- 1159US11427586B21,2,4-oxadiazole derivatives as liver X receptor agonistsNOVARTIS AG·Filed 2020·Granted Aug 30, 2022·0 cites·21 claims
- 1259US11026993B2Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2019·Granted Jun 8, 2021·0 cites·33 claims
- 1358US10202400B2Cortistatin analogues and syntheses thereofHARVARD COLLEGE·Filed 2017·Granted Feb 12, 2019·0 cites·21 claims
- 1453US9505755B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Nov 29, 2016·0 cites·11 claims
- 1552US12209144B2Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2019·Granted Jan 28, 2025·0 cites·1 claims
- 1650US2020325518A1Systems and Methods for Metabolic Assessment Utilizing 1-Methoxy-PMS FieldSELUX DIAGNOSTICS INC·Filed 2020·Application pending·0 cites
- 1748US10048269B2Assay methods involving dissociable nanoparticlesSELUX DIAGNOSTICS INC·Filed 2015·Granted Aug 14, 2018·0 cites·6 claims
- 1846US2023089867A1Cyclic pentamer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorderNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1938US2019091673A1Dissociable nanoparticles with inter alia transition-metal complex catalystsSELUX DIAGNOSTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alec Nathanson Flyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →